Abstract
Abstract
Background
Nimodipine is routinely administered in patients with aneurysmal subarachnoid hemorrhage (aSAH). However, the effect of nimodipine on oxygen exchange in the lungs is insufficiently explored.
Methods
The study explored nimodipine medication in artificially ventilated patients with aSAH. The data collection period was divided into nimodipine-dependent (ND) and nimodipine-independent (NID) periods. Values for arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2) were collected and compared between the periods. Patients were divided in those with lung injury (LI), defined as median Horowitz index (PaO2/FiO2) ≤40 kPa (≤300 mmHg), and without and in those with lower respiratory tract infection (LRTI) and without.
Results
A total of 53 out of 150 patients were artificially ventilated, and in 29 patients, the Horowitz index could be compared between ND and NID periods. A linear mixed model showed that during ND period the Horowitz index was 2.3 kPa (95% CI, 1.0–3.5 kPa, P<0.001) lower when compared to NID period. The model suggested that in the presence of LI, ND period is associated with a decrease of the index by 2.8 kPa (95% CI, 1.2–4.3 kPa, P<0.001). The decrease was more pronounced with LRTI than without: 3.4 kPa (95% CI, 0.8–6.1 kPa) vs. 2.1 kPa (95% CI, 0.7–3.4 kPa), P=0.011 and P=0.002, respectively.
Conclusions
In patients with LI or LRTI in the context of aSAH, pulmonary function may worsen with nimodipine treatment. The drop of 2 to 3 kPa of the Horowitz index in patients with no lung pathology may not outweigh the benefits of nimodipine. However, in individuals with concomitant lung injury, the effect may be clinically relevant.
Funder
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Innosuisse - Schweizerische Agentur für Innovationsförderung
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Surgery
Reference21 articles.
1. Allen G, Ahn H, Preziosi T, Battye R, Boone S, Boone S, Chou S, Kelly D, Weir B, Crabbe R, Lavik P, Rosenbloom S, Dorsey F, Ingram C, Mellits D, Bertsch L, Boisvert D, Hundley M, Johnson R, Strom J, Transou C (1983) Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:619–624
2. Baker M, Bastin M, Cook A, Fraser J, Hessel E 2nd (2015) Hypoxemia associated with nimodipine in a patient with an aneurysmal subarachnoid hemorrhage. Am J Health Syst Pharm 72:39–43
3. Bayer Pharmaceuticals Corporation (2005) Nimotop (nimodipine) Capsules for oral use. FDA approved Labeling text. 2005;NDA 18-869/S-014. https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018869s014lbl.pdf. Accssed 15 Nov 2020
4. Bele S, Proescholdt MA, Hochreiter A, Schuierer G, Scheitzach J, Wendl C, Kieninger M, Schneiker A, Bründl E, Schödel P, Schebesch K, Brawanski A (2015) Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results. Acta Neurochir 157:2041–2050
5. Boldt J, Von Bormann B, Kling D, Ratthey K, Hempelmann G (1987) Influence of nimodipine and nifedipine on intrapulmonary shunting--a comparison to other vasoactive drugs. Intensive Care Med 13:52–56
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献